[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hemophilia Drugs Market Data Survey Report 2025

January 2018 | 89 pages | ID: G086D2D6D8EEN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Hemophilia Drugs market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • Baxalta
  • Bayer
  • CSL Behring
  • Novo Nordisk
  • Pfizer
  • Roche
  • Roche
  • Amarna Therapeutics
  • Asklepios BioPharmaceutical
  • Biogen
  • BioMarin
  • Catalyst Bioscience
  • Chiesi Farmaceutici
  • Dimension Therapeutics
  • Emergent BioSolutions
  • Grifols, Kedrion Biopharma
  • Octapharma
  • rEVO Biologics
  • OPKO Biologics
  • Sangamo Biosciences
  • Spark Therapeutics
  • Swedish Orphan Biovitrum
Major applications as follows:
  • Clinic
  • Hospital
Major Type as follows:
  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Baxalta
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Bayer
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 CSL Behring
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Novo Nordisk
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Pfizer
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Roche
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Roche
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Amarna Therapeutics
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Asklepios BioPharmaceutical
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Biogen
  3.10.1 Company Information
  3.10.2 Product Specifications
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 BioMarin
3.12 Catalyst Bioscience
3.13 Chiesi Farmaceutici
3.14 Dimension Therapeutics
3.15 Emergent BioSolutions
3.16 Grifols, Kedrion Biopharma
3.17 Octapharma
3.18 rEVO Biologics
3.19 OPKO Biologics
3.20 Sangamo Biosciences
3.21 Spark Therapeutics
3.22 Swedish Orphan Biovitrum

4 MAJOR APPLICATION

4.1 Clinic
  4.1.1 Overview
  4.1.2 Clinic Market Size and Forecast
4.2 Hospital
  4.2.1 Overview
  4.2.2 Hospital Market Size and Forecast

5 MARKET BY TYPE

5.1 Hemophilia A
  5.1.1 Overview
  5.1.2 Hemophilia A Market Size and Forecast
5.2 Hemophilia B
  5.2.1 Overview
  5.2.2 Hemophilia B Market Size and Forecast
5.3 Hemophilia C
  5.3.1 Overview
  5.3.2 Hemophilia C Market Size and Forecast

6 CONCLUSION

LIST OF TABLES

Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Baxalta 
Tab Sales Revenue, Volume, Price, Cost and Margin of Bayer 
Tab Sales Revenue, Volume, Price, Cost and Margin of CSL Behring 
Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk 
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer 
Tab Sales Revenue, Volume, Price, Cost and Margin of Roche 
Tab Sales Revenue, Volume, Price, Cost and Margin of Roche 
Tab Sales Revenue, Volume, Price, Cost and Margin of Amarna Therapeutics 
Tab Sales Revenue, Volume, Price, Cost and Margin of Asklepios BioPharmaceutical 
Tab Sales Revenue, Volume, Price, Cost and Margin of Biogen 
Tab Sales Revenue, Volume, Price, Cost and Margin of BioMarin 
Tab Sales Revenue, Volume, Price, Cost and Margin of Catalyst Bioscience 
Tab Sales Revenue, Volume, Price, Cost and Margin of Chiesi Farmaceutici 
Tab Sales Revenue, Volume, Price, Cost and Margin of Dimension Therapeutics 
Tab Sales Revenue, Volume, Price, Cost and Margin of Emergent BioSolutions 
Tab Sales Revenue, Volume, Price, Cost and Margin of Grifols, Kedrion Biopharma 
Tab Sales Revenue, Volume, Price, Cost and Margin of Octapharma 
Tab Sales Revenue, Volume, Price, Cost and Margin of rEVO Biologics 
Tab Sales Revenue, Volume, Price, Cost and Margin of OPKO Biologics 
Tab Sales Revenue, Volume, Price, Cost and Margin of Sangamo Biosciences 
Tab Sales Revenue, Volume, Price, Cost and Margin of Spark Therapeutics 
Tab Sales Revenue, Volume, Price, Cost and Margin of Swedish Orphan Biovitrum

LIST OF FIGURES

Fig Global Hemophilia Drugs Market Size and CAGR 2011-2017 (Million USD)
Fig Global Hemophilia Drugs Market Size and CAGR 2011-2017 (Volume)
Fig Global Hemophilia Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Hemophilia Drugs Market Forecast and CAGR 2018-2025 (Volume)
Fig Clinic  Market Size and CAGR 2011-2017 (Million USD)
Fig Clinic  Market Size and CAGR 2011-2017 (Volume)
Fig Clinic  Market Forecast and CAGR 2018-2025 (Million USD)
Fig Clinic  Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospital Market Size and CAGR 2011-2017 (Million USD)
Fig Hospital Market Size and CAGR 2011-2017 (Volume)
Fig Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)
Fig Hemophilia A  Market Size and CAGR 2011-2017 (Million USD)
Fig Hemophilia A  Market Size and CAGR 2011-2017 (Volume)
Fig Hemophilia A  Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hemophilia A  Market Forecast and CAGR 2018-2025 (Volume)
Fig Hemophilia B  Market Size and CAGR 2011-2017 (Million USD)
Fig Hemophilia B  Market Size and CAGR 2011-2017 (Volume)
Fig Hemophilia B  Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hemophilia B  Market Forecast and CAGR 2018-2025 (Volume)
Fig Hemophilia C Market Size and CAGR 2011-2017 (Million USD)
Fig Hemophilia C Market Size and CAGR 2011-2017 (Volume)
Fig Hemophilia C Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hemophilia C Market Forecast and CAGR 2018-2025 (Volume)


More Publications